MH
Therapeutic Areas
Renasant Bio Pipeline
| Drug | Indication | Phase |
|---|---|---|
| Small Molecule Corrector Program | Autosomal Dominant Polycystic Kidney Disease (ADPKD) | Pre-clinical |
| Small Molecule Potentiator Program | Autosomal Dominant Polycystic Kidney Disease (ADPKD) | Pre-clinical |
Leadership Team at Renasant Bio
EC
Emily Conley, PhD
Chief Executive Officer
GG
Gus Gustafson, PhD
Chief Scientific Officer
BT
Barry Toure, PhD
Senior Vice President, Drug Discovery
RG
Rachel Gallagher, PhD
Vice President, Biology
JR
Jeremy Reiter, MD, PhD
Scientific Co-Founder, SAB Member
MD
Markus Delling, PhD
Scientific Co-Founder, SAB Member